Clinical Trial

Effect of Essential Aminoacid Supplementation and Exercise on Skeletal Muscle Function in Hemodialysis Patients

Recruiting
View on ClinicalTrials.gov →
Summary
Sarcopenia can be easily observed in patients with hemodialysis. However, there were few studies on the precise concept and diagnostic criteria for sarcopenia in patients with hemodialysis. The investigators have already recognized the sarcopenia-associated mortality and morbidity in patients with hemodialysis. However, intervention studies on hemodialysis patients with sarcopenia have not been conducted until now. In 2021, the investigators conducted a pilot study to evaluate the effectiveness of the combined exercise and nutrition intervention for sarcopenia in patients with hemodialysis to confirm the effectiveness. This study is a follow-up study, conducted as a randomized controlled trial.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-05-30; most recent amendment 2026-03-17.
Status change: Not Yet Recruiting → Recruiting 2023-08-29
Trial Details
NCT Number NCT05884138
Lead Sponsor Chungnam National University Hospital
Conditions Sarcopenia
Enrollment 40 participants
Start Date 2023-08-28
Primary Completion 2024-12-31 (estimated)
Study Completion 2026-08-23 (estimated)
Updated on ClinicalTrials.gov 2026-03-18